|
Timothy Maudlin has served as a member of our Board of Directors since February 2002 and was appointed Lead Director in January 2007. Mr. Maudlin is also a director of Sucampo Pharmaceuticals Inc. a position held since September 2006 and is currently a member of its Audit Committee and its Nominating and Corporate Governance Committee. Mr. Maudlin currently serves on the board of directors of three private companies. Mr. Maudlin served as a managing partner of Medical Innovation Partners a venture capital firm from 1989 until 2007. From 1999 to 2001 he served as a principal and as chief financial officer of Venturi Group LLC an incubator and venture capital firm. Beginning in 1984 until June 2006 Mr. Maudlin served on the board of directors of Curative Health Services Inc. (Curative) a biopharmaceutical company and from February 2005 until June 2006 Mr. Maudlin served as its chairman. In March 2006 Curative filed a voluntary petition for bankruptcy under Chapter 11 and in June 2006 it emerged from bankruptcy. He is a certified public accountant and holds a B.A. from St. Olaf College and a M.M. from Kellogg School of Management at Northwestern University. | 